120 related articles for article (PubMed ID: 28565893)
1. Positron emission tomography/computer tomography in gastrointestinal malignancies: current potential and challenges.
Tind S; Vestergaard S; Farahani ZA; Hess S
Minerva Chir; 2017 Oct; 72(5):397-415. PubMed ID: 28565893
[TBL] [Abstract][Full Text] [Related]
2. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Donswijk ML; Hess S; Mulders T; Lam MG
PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
[TBL] [Abstract][Full Text] [Related]
3. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Buchmann I; Ganten TM; Haberkorn U
Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
[TBL] [Abstract][Full Text] [Related]
4. Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.
Smyth EC; Shah MA
World J Gastroenterol; 2011 Dec; 17(46):5059-74. PubMed ID: 22171140
[TBL] [Abstract][Full Text] [Related]
5. Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update.
Kitajima K; Nakajo M; Kaida H; Minamimoto R; Hirata K; Tsurusaki M; Doi H; Ueno Y; Sofue K; Tamaki Y; Yamakado K
Nagoya J Med Sci; 2017 Nov; 79(4):527-543. PubMed ID: 29238109
[TBL] [Abstract][Full Text] [Related]
6. Role of positron emission tomography-computed tomography in gastrointestinal malignancies.
Banks KP; Song WS
Radiol Clin North Am; 2013 Sep; 51(5):799-831. PubMed ID: 24010907
[TBL] [Abstract][Full Text] [Related]
7. [Roles of F-18 FDG PET or PET/CT for the evaluation of gastrointestinal malignancies].
Yun M; Kim BI
Korean J Gastroenterol; 2006 Dec; 48(6):378-87. PubMed ID: 17189920
[TBL] [Abstract][Full Text] [Related]
8. Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography for the detection of proximal synchronous lesions in patients with obstructive colorectal cancer.
Kim WS; Lee HS; Lee JM; Kwak MS; Hwang SW; Park SH; Yang DH; Kim KJ; Myung SJ; Yang SK; Byeon JS
J Gastroenterol Hepatol; 2017 Feb; 32(2):401-408. PubMed ID: 27418280
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies.
Howard BA; Wong TZ
Radiol Clin North Am; 2021 Sep; 59(5):737-753. PubMed ID: 34392916
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET scanning in the diagnosis of gastrointestinal cancers.
van Kouwen MC; Oyen WJ; Nagengast FM; Jansen JB; Drenth JP
Scand J Gastroenterol Suppl; 2004; (241):85-92. PubMed ID: 15696855
[TBL] [Abstract][Full Text] [Related]
11. Detection of extra-regional tumour recurrence with
Brar H; May T; Tau N; Langer D; MacCrostie P; Han K; Metser U
Clin Radiol; 2017 Apr; 72(4):302-306. PubMed ID: 28108013
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
13. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
[TBL] [Abstract][Full Text] [Related]
14. Present and future role of FDG-PET/CT imaging in the management of breast cancer.
Kitajima K; Miyoshi Y
Jpn J Radiol; 2016 Mar; 34(3):167-80. PubMed ID: 26733340
[TBL] [Abstract][Full Text] [Related]
15. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
Buchs NC; Bühler L; Bucher P; Willi JP; Frossard JL; Roth AD; Addeo P; Rosset A; Terraz S; Becker CD; Ratib O; Morel P
J Gastroenterol Hepatol; 2011 Apr; 26(4):657-62. PubMed ID: 21155879
[TBL] [Abstract][Full Text] [Related]
16. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
[TBL] [Abstract][Full Text] [Related]
17.
Lehmann K; Eshmuminov D; Bauerfeind P; Gubler C; Veit-Haibach P; Weber A; Abdul-Rahman H; Fischer M; Reiner C; Schneider PM
Eur J Surg Oncol; 2017 Jan; 43(1):196-202. PubMed ID: 27692533
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of gastrointestinal tract malignancies using positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG)].
Kato H; Sohda M; Kuwano H
Nihon Shokakibyo Gakkai Zasshi; 2004 Dec; 101(12):1292-301. PubMed ID: 15651391
[No Abstract] [Full Text] [Related]
19. PET imaging in assessing gastrointestinal tumors.
Hustinx R
Radiol Clin North Am; 2004 Nov; 42(6):1123-39, ix. PubMed ID: 15488562
[TBL] [Abstract][Full Text] [Related]
20. Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms.
Gupta N; Bradfield H
Semin Nucl Med; 1996 Jan; 26(1):65-73. PubMed ID: 8623053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]